Evidence map›Paper›PMID 27160179›Full record

ArticleProtein engineering, design & selection : PEDS2016

Modulating non-native aggregation and electrostatic protein-protein interactions with computationally designed single-point mutations.

C J O'Brien, M A Blanco, J A Costanzo, M Enterline, E J Fernandez, A S Robinson, C J Roberts

Abstract read
In one paragraph

Article in Protein engineering, design & selection : PEDS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Solubility of proteins.ADMET & DMPK · 2020
    Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

C J O'BrienDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.
M A BlancoDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.
J A CostanzoDepartment of Chemical Engineering, University of Virginia, Charlottesville, VA 22903, USA.
M EnterlineDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.
E J FernandezDepartment of Chemical Engineering, University of Virginia, Charlottesville, VA 22903, USA.
A S RobinsonDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.
C J RobertsDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.

Funding

Biotechnology Research Partnerships Renewal: Aggregation of Therapeutic ProteinsR01EB006006 · NIBIB · UNIVERSITY OF COLORADO · PI RANDOLPH, THEODORE W · 2006 to 2017
$7.2M
NIBIB NIH HHS R01 EB006006
6 · The paper itself

Abstract

Non-native protein aggregation is a ubiquitous challenge in the production, storage and administration of protein-based biotherapeutics. This study focuses on altering electrostatic protein-protein interactions as a strategy to modulate aggregation propensity in terms of temperature-dependent aggregation rates, using single-charge variants of human γ-D crystallin. Molecular models were combined to predict amino acid substitutions that would modulate protein-protein interactions with minimal effects on conformational stability. Experimental protein-protein interactions were quantified by the Kirkwood-Buff integrals (G22) from laser scattering, and G22 showed semi-quantitative agreement with model predictions. Experimental initial-rates for aggregation showed that increased (decreased) repulsive interactions led to significantly increased (decreased) aggregation resistance, even based solely on single-point mutations. However, in the case of a particular amino acid (E17), the aggregation mechanism was altered by substitution with R or K, and this greatly mitigated improvements in aggregation resistance. The results illustrate that predictions based on native protein-protein interactions can provide a useful design target for engineering aggregation resistance; however, this approach needs to be balanced with consideration of how mutations can impact aggregation mechanisms.

Indexed as

Mutagenesis, Site-DirectedProtein AggregatesCloning, MolecularEscherichia coligamma-CrystallinsHumansModels, MolecularPoint MutationProtein Interaction MapsProtein StabilityStatic ElectricityTemperatureCRYGD protein, humangamma-CrystallinsProtein Aggregatescomputational designprotein aggregationprotein engineeringprotein–protein interactions

Identifiers

PMID27160179
PMCPMC4867096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.